Zevra Therapeutics (ZVRA) Chief Legal & Compliance Rahsaan Thompson Sells 42,666 Shares

What Happened

• Rahsaan Thompson, Chief Legal & Compliance Officer of Zevra Therapeutics (ZVRA), sold 42,666 shares on August 14, 2026. The proceeds reported equal $474,774, based on a weighted average sale price of $11.13 per share. The filing lists the transaction as an open-market/private sale (code S).

Key Details

• Transaction date: 2026-08-14
• Price: weighted average $11.13 per share; individual trade prices ranged $10.86–$11.36 (multiple trades) — filer can provide per-trade breakdown on request (Footnote F2).
• Total proceeds: $474,774
• Shares owned after transaction: not disclosed on the Form 4
• Footnote: transaction executed under a pre-established 10b5‑1 plan adopted 05-15-2026 (Footnote F1)
• Filing date: Form 4 filed 2026-08-17 — within the standard two-business-day filing window for Form 4s

Context

• This was a sale, not a purchase or option exercise. Sales are often routine (e.g., planned under 10b5‑1 plans) and do not necessarily indicate a change in the insider’s view of the company. The presence of a 10b5‑1 plan suggests the trades were pre-planned; the filing discloses the plan adoption date and that the sale occurred in multiple transactions.